| Cash and cash equivalents | 6.94M |
| Short-term investments | |
| Interest and other receivables | |
| Prepaids and other current assets | |
| Total current assets | 7.44M |
| Property and equipment, net | 665.59K |
| Restricted investments | |
| Other assets | 168.6K |
| Total assets | 15.1M |
| Accounts payable | 608.37K |
| Accrued clinical trial costs | 488.25K |
| Accrued compensation | 640.19K |
| Accrued liabilities | 666.15K |
| Current portion of facility exit costs | |
| Total current liabilities | 4.29M |
| Noncurrent portion of facility exit costs | |
| Long-term deferred rent | |
| Commitments and contingencies | 0 |
| Common stock | |
| Additional paid-in capital | 80.6M |
| Accumulated other comprehensive income (loss) | |
| Accumulated deficit | -73.15M |
| Total stockholders' equity | 7.51M |
| Total liabilities and stockholders' equity | 15.1M |